DexCom, a glucose biosensing know-how firm, unveiled its proprietary Generative AI (GenAI) platform on Tuesday, December 17, turning into the primary CGM producer to combine superior AI into glucose biosensing know-how. The brand new Dexcom GenAI platform leverages Google Cloud’s Vertex AI and Gemini fashions to analyse particular person well being knowledge, providing personalised insights that hyperlink way of life selections to glucose ranges. This goals to assist customers make knowledgeable selections to enhance metabolic well being, the corporate mentioned.
Additionally Learn: Nvidia and Companions Develop AI Mannequin to Predict Future Glucose Ranges in People
Stelo GenAI Platform
Stelo, the primary over-the-counter glucose biosensor FDA-cleared within the US, is the primary Dexcom product to make use of GenAI know-how to supply weekly insights. DexCom mentioned the enhancement of Stelo’s Weekly Insights function started rolling out to customers this week. GenAI-powered messaging enhances Stelo’s current Weekly Insights by offering customers with extra personalised ideas, suggestions, and training associated to weight loss program, train, and sleep throughout the Stelo app, delivering actionable well being suggestions.
GenAI-Powered Well being Developments
“The launch of our GenAI platform reinforces our long-standing fame because the glucose biosensing chief and opens the door for future developments throughout our product portfolio,” mentioned Jake Leach, government vp and chief working officer at Dexcom. “Innovation is on the core of what we do. We look ahead to introducing further GenAI-powered options over the following 12 months to assist customers contextualise their well being data and make proactive, knowledgeable way of life selections.”
Additionally Learn: Microsoft Pronounces New AI Fashions and Options for Healthcare
Leveraged Google Cloud Platform
DexCom mentioned it leveraged Google Cloud’s Vertex AI platform and Gemini fashions as the muse for constructing its GenAI platform.
“By bringing the facility of Google Cloud’s Vertex AI and Gemini to Dexcom’s revolutionary glucose biosensing know-how, customers may have extra personalised insights to assist them make the perfect selections for his or her well being,” mentioned Chris Sakalosky, vp of Strategic Industries for Google Cloud. “Dexcom is empowering folks to take management of their metabolic well being like by no means earlier than, and it is only the start of what is attainable as main organisations carry GenAI to healthcare.”
Additionally Learn: GE HealthCare Launches AI Innovation Lab to Drive Medical Developments
Dexcom says the “proprietary platform lays the muse for future GenAI developments throughout the Dexcom product portfolio that may additional empower its tens of millions of customers to assist take management of their well being.”
